 Pfizer countered that it met all the necessary regulations.The drug was approved for general use in the US, and eventually withdrawn due to hepatotoxicity.AZT trials conducted on HIV-positive African subjects by U.S. physicians and the University of Zimbabwe were not performed with proper informed consent.